1 |
|
Direct p53 effectors
|
128 |
2.021 |
SuperPathway |
|
Genes names |
- Junction Mediating And Regulatory Protein, P53 Cofactor
- P53 Apoptosis Effector Related To PMP22
- P53-Induced Death Domain Protein 1
- Tumor Protein P53
- Tumor Protein P53 Inducible Protein 3
- Tumor Protein P53 Inducible Nuclear Protein 1
|
Pathways |
|
|
2 |
|
p53 transcriptional gene network
|
95 |
1.953 |
SuperPathway |
- p53 transcriptional gene network
|
Genes names |
- P53 Apoptosis Effector Related To PMP22
- P53-Induced Death Domain Protein 1
- Tumor Protein P53 Regulated Apoptosis Inducing Protein 1
- Tumor Protein P53 Inducible Protein 3
- Tumor Protein P53 Inducible Nuclear Protein 1
|
Pathways |
- p53 transcriptional gene network
|
|
3 |
|
p53 Signaling
|
117 |
1.801 |
SuperPathway |
|
Genes names |
|
Pathways |
- p53 Pathway
- p53 Signaling
|
|
4 |
|
miRNA regulation of p53 pathway in prostate cancer
|
32 |
1.791 |
SuperPathway |
- miRNA regulation of p53 pathway in prostate cancer
|
Genes names |
- P53 Apoptosis Effector Related To PMP22
- Tumor Protein P53
- Tumor Protein P53 Regulated Apoptosis Inducing Protein 1
|
Pathways |
- miRNA regulation of p53 pathway in prostate cancer
|
|
5 |
|
p53 pathway
|
50 |
1.791 |
SuperPathway |
|
Genes names |
- MDM4 Regulator Of P53
- Tumor Protein P53
- Tumor Protein P53 Regulated Apoptosis Inducing Protein 1
|
Pathways |
|
|
6 |
|
Regulation of activated PAK-2p34 by proteasome mediated degradation
|
978 |
1.775 |
Genes names |
- MDM4 Regulator Of P53
- Tumor Protein P53
|
Pathways |
- Stabilization of p53
- p53-Dependent G1/S DNA damage checkpoint
- p53-Independent DNA Damage Response
- p53-Dependent G1 DNA Damage Response
- p53-Independent G1/S DNA damage checkpoint
|
|
7 |
|
Transcriptional activation of p53 responsive genes
|
4 |
1.557 |
SuperPathway |
- Transcriptional activation of p53 responsive genes
|
Genes names |
|
Pathways |
- Transcriptional activation of p53 responsive genes
|
|
8 |
|
TP53 Regulates Transcription of Cell Death Genes
|
44 |
1.439 |
Genes names |
- P53 Apoptosis Effector Related To PMP22
- P53-Induced Death Domain Protein 1
- Tumor Protein P53
- Tumor Protein P53 Regulated Apoptosis Inducing Protein 1
- Tumor Protein P53 Binding Protein 2
- Tumor Protein P53 Inducible Protein 3
- Tumor Protein P53 Inducible Nuclear Protein 1
|
Pathways |
- TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
|
|
9 |
|
Apoptotic Pathways in Synovial Fibroblasts
|
731 |
1.232 |
Genes names |
- P53 Apoptosis Effector Related To PMP22
- Tumor Protein P53
- Tumor Protein P53 Regulated Apoptosis Inducing Protein 1
- Tumor Protein P53 Binding Protein 2
|
Pathways |
|
|
10 |
|
Gene expression (Transcription)
|
1546 |
0.962 |
Genes names |
- Junction Mediating And Regulatory Protein, P53 Cofactor
- MDM4 Regulator Of P53
- P53 Apoptosis Effector Related To PMP22
- P53-Induced Death Domain Protein 1
- Tumor Protein P53
- Tumor Protein P53 Regulated Apoptosis Inducing Protein 1
- Tumor Protein P53 Binding Protein 2
- Tumor Protein P53 Inducible Protein 3
- Tumor Protein P53 Inducible Nuclear Protein 1
|
|
11 |
|
Regulation of TP53 Activity
|
362 |
0.962 |
Genes names |
- Junction Mediating And Regulatory Protein, P53 Cofactor
- MDM4 Regulator Of P53
- P53 Apoptosis Effector Related To PMP22
- P53-Induced Death Domain Protein 1
- Tumor Protein P53
- Tumor Protein P53 Regulated Apoptosis Inducing Protein 1
- Tumor Protein P53 Binding Protein 2
- Tumor Protein P53 Inducible Protein 3
- Tumor Protein P53 Inducible Nuclear Protein 1
|
|
12 |
|
TP53 Regulates Transcription of Cell Cycle Genes
|
48 |
0.912 |
Genes names |
|
Pathways |
- TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
|
|
13 |
|
Proteolysis Putative SUMO-1 pathway
|
40 |
0.912 |
Genes names |
|
Pathways |
- DNA damage Role of SUMO in p53 regulation
|
|
14 |
|
ATM Pathway
|
51 |
0.641 |
Genes names |
- MDM4 Regulator Of P53
- P53-Induced Death Domain Protein 1
- Tumor Protein P53
- Tumor Protein P53 Binding Protein 1
|
|
15 |
|
DNA Damage
|
296 |
0.555 |
Genes names |
- Cell Death Inducing P53 Target 1
- Tumor Protein P53
- Tumor Protein P53 Binding Protein 1
|
|
16 |
|
Metabolism of proteins
|
1970 |
0.555 |
Genes names |
- MDM4 Regulator Of P53
- Tumor Protein P53
- Tumor Protein P53 Binding Protein 1
|
|
17 |
|
miRNA regulation of DNA damage response
|
74 |
0.555 |
Genes names |
- P53-Induced Death Domain Protein 1
- Tumor Protein P53
- Tumor Protein P53 Regulated Apoptosis Inducing Protein 1
|
|
18 |
|
Cell Cycle, Mitotic
|
691 |
0.555 |
Genes names |
- MDM4 Regulator Of P53
- Tumor Protein P53
- Tumor Protein P53 Binding Protein 1
|
|
19 |
|
Cell Cycle Checkpoints
|
293 |
0.555 |
Genes names |
- MDM4 Regulator Of P53
- Tumor Protein P53
- Tumor Protein P53 Binding Protein 1
|
|
20 |
|
Programmed Cell Death
|
213 |
0.454 |
Genes names |
- Tumor Protein P53
- Tumor Protein P53 Binding Protein 2
|
|
21 |
|
Transport of the SLBP independent Mature mRNA
|
285 |
0.454 |
Genes names |
- Tumor Protein P53
- Tumor Protein P53 Binding Protein 1
|
|
22 |
|
DNA IR-double strand breaks and cellular response via ATM
|
65 |
0.454 |
Genes names |
- Tumor Protein P53
- Tumor Protein P53 Binding Protein 1
|
|
23 |
|
Death Receptor Signaling Pathway
|
119 |
0.454 |
Genes names |
- P53-Induced Death Domain Protein 1
- Tumor Protein P53
|
|
24 |
|
p73 transcription factor network
|
76 |
0.454 |
Genes names |
- Tumor Protein P53 Regulated Apoptosis Inducing Protein 1
- Tumor Protein P53 Inducible Protein 3
|
|
25 |
|
DNA damage_Role of Brca1 and Brca2 in DNA repair
|
40 |
0.454 |
Genes names |
- Tumor Protein P53
- Tumor Protein P53 Binding Protein 1
|
|
26 |
|
MIF Mediated Glucocorticoid Regulation
|
681 |
0.454 |
Genes names |
- Tumor Protein P53
- Tumor Protein P53 Binding Protein 2
|
|
27 |
|
Cellular responses to stimuli
|
802 |
0.454 |
Genes names |
- MDM4 Regulator Of P53
- Tumor Protein P53
|
|
28 |
|
ERK Signaling
|
1185 |
0.454 |
Genes names |
- Tumor Protein P53
- Tumor Protein P53 Binding Protein 2
|
|
29 |
|
Deubiquitination
|
298 |
0.454 |
Genes names |
- MDM4 Regulator Of P53
- Tumor Protein P53
|
|
30 |
|
11p11.2 copy number variation syndrome
|
144 |
0.454 |
Genes names |
- Tumor Protein P53
- Tumor Protein P53 Inducible Protein 11
|
|
31 |
|
Oncogene Induced Senescence
|
33 |
0.454 |
Genes names |
- MDM4 Regulator Of P53
- Tumor Protein P53
|
|
32 |
|
DNA Double Strand Break Response
|
91 |
0.454 |
Genes names |
- Tumor Protein P53
- Tumor Protein P53 Binding Protein 1
|
|
33 |
|
Prolactin Signaling
|
432 |
0.454 |
Genes names |
- MDM4 Regulator Of P53
- Tumor Protein P53
|
|
34 |
|
Validated transcriptional targets of TAp63 isoforms
|
54 |
0.454 |
Genes names |
- P53 Apoptosis Effector Related To PMP22
- Tumor Protein P53 Inducible Protein 3
|
|
35 |
|
GPCR Pathway
|
712 |
0.454 |
Genes names |
- Tumor Protein P53
- Tumor Protein P53 Binding Protein 2
|
|
36 |
|
Cellular Senescence
|
196 |
0.454 |
Genes names |
- MDM4 Regulator Of P53
- Tumor Protein P53
|
|
37 |
|
Homology Directed Repair
|
346 |
0.454 |
Genes names |
- Tumor Protein P53
- Tumor Protein P53 Binding Protein 1
|
|
38 |
|
DNA IR-damage and cellular response via ATR
|
81 |
0.454 |
Genes names |
- Tumor Protein P53
- Tumor Protein P53 Binding Protein 1
|
|
39 |
|
Apoptosis modulation and signaling
|
32 |
0.454 |
Genes names |
- P53-Induced Death Domain Protein 1
- Tumor Protein P53
|
|
40 |
|
Malignant pleural mesothelioma
|
409 |
0.454 |
Genes names |
- MDM4 Regulator Of P53
- Tumor Protein P53
|
|
41 |
|
P38 MAPK Signaling Pathway (sino)
|
61 |
0.454 |
Genes names |
- Tumor Protein P53 Regulated Apoptosis Inducing Protein 1
- Tumor Protein P53 Inducible Protein 3
|
|
42 |
|
Intrinsic Pathway for Apoptosis
|
55 |
0.454 |
Genes names |
- Tumor Protein P53
- Tumor Protein P53 Binding Protein 2
|
|
43 |
|
Regulation of TP53 Expression and Degradation
|
37 |
0.454 |
Genes names |
- MDM4 Regulator Of P53
- Tumor Protein P53
|
|
44 |
|
Beta-Adrenergic Signaling
|
333 |
0.321 |
Genes names |
- Tumor Protein P53 Binding Protein 2
|
|
45 |
|
Pathways affected in adenoid cystic carcinoma
|
62 |
0.321 |
|
46 |
|
Apoptosis and Autophagy
|
185 |
0.321 |
Genes names |
- Cell Death Inducing P53 Target 1
|
|
47 |
|
Small cell lung cancer
|
96 |
0.321 |
|
48 |
|
16p11.2 proximal deletion syndrome
|
72 |
0.321 |
|
49 |
|
PIP3 activates AKT signaling
|
310 |
0.321 |
|
50 |
|
AMP-activated protein kinase signaling
|
100 |
0.321 |
|
51 |
|
BRCA1 Pathway
|
64 |
0.321 |
|
52 |
|
Autophagy in pancreatic ductal adenocarcinoma
|
20 |
0.321 |
|
53 |
|
Signaling mediated by p38-alpha and p38-beta
|
33 |
0.321 |
|
54 |
|
Autophagy pathway
|
228 |
0.321 |
|
55 |
|
Aurora A signaling
|
33 |
0.321 |
|
56 |
|
PLK3 signaling events
|
6 |
0.321 |
|
57 |
|
Akt Signaling
|
682 |
0.321 |
|
58 |
|
LKB1 signaling events
|
37 |
0.321 |
|
59 |
|
Unfolded protein response
|
22 |
0.321 |
|
60 |
|
Breast cancer pathway
|
199 |
0.321 |
|
61 |
|
Amyotrophic lateral sclerosis (ALS)
|
36 |
0.321 |
|
62 |
|
ATM signaling in development and disease
|
45 |
0.321 |
Genes names |
- Tumor Protein P53 Binding Protein 1
|
|
63 |
|
DNA damage_ATM/ATR regulation of G1/S checkpoint
|
44 |
0.321 |
|
64 |
|
NF-kappaB Signaling
|
327 |
0.321 |
Genes names |
- Cell Death Inducing P53 Target 1
|
|
65 |
|
MAPK Signaling: Mitogens
|
108 |
0.321 |
|
66 |
|
WNT Signaling
|
250 |
0.321 |
|
67 |
|
MAPK signaling pathway
|
244 |
0.321 |
|
68 |
|
mTOR Signaling
|
139 |
0.321 |
|
69 |
|
Apoptosis and survival FAS signaling cascades
|
108 |
0.321 |
Genes names |
- P53-Induced Death Domain Protein 1
|
|
70 |
|
Hepatocyte growth factor receptor signaling
|
115 |
0.321 |
|
71 |
|
APC-Cdc20 mediated degradation of Nek2A
|
50 |
0.321 |
|
72 |
|
miRNAs involved in DNA damage response
|
67 |
0.321 |
|
73 |
|
NGF Pathway
|
87 |
0.321 |
|
74 |
|
Validated transcriptional targets of deltaNp63 isoforms
|
47 |
0.321 |
Genes names |
- P53 Apoptosis Effector Related To PMP22
|
|
75 |
|
Signaling events mediated by HDAC Class III
|
38 |
0.321 |
|
76 |
|
Endometrial cancer
|
201 |
0.321 |
|
77 |
|
Interleukin-1 family signaling
|
153 |
0.321 |
|
78 |
|
MyD88 dependent cascade initiated on endosome
|
175 |
0.321 |
|
79 |
|
fMLP Pathway
|
266 |
0.321 |
|
80 |
|
GADD45 Pathway
|
32 |
0.321 |
|
81 |
|
PI3K-Akt signaling pathway
|
390 |
0.321 |
|
82 |
|
Keratinization
|
215 |
0.321 |
Genes names |
- P53 Apoptosis Effector Related To PMP22
|
|
83 |
|
IL-18 signaling pathway
|
50 |
0.321 |
|
84 |
|
Chks in Checkpoint Regulation
|
186 |
0.321 |
|
85 |
|
Defective Intrinsic Pathway for Apoptosis
|
25 |
0.321 |
|
86 |
|
AP-1 transcription factor network
|
69 |
0.321 |
|
87 |
|
Doxorubicin Pathway, Pharmacokinetics
|
28 |
0.321 |
|
88 |
|
DNA damage response (only ATM dependent)
|
101 |
0.321 |
|
89 |
|
DNA Damage Induced 14-3-3Sigma Signaling
|
19 |
0.321 |
|
90 |
|
Glycolysis in senescence
|
8 |
0.321 |
|
91 |
|
let-7 inhibition of ES cell reprogramming
|
21 |
0.321 |
|
92 |
|
BARD1 signaling events
|
29 |
0.321 |
|
93 |
|
Ovarian tumor domain proteases
|
39 |
0.321 |
|
94 |
|
p70S6K Signaling
|
392 |
0.321 |
Genes names |
- Tumor Protein P53 Binding Protein 2
|
|
95 |
|
T-cell activation SARS-CoV-2
|
116 |
0.321 |
|
96 |
|
Development EGFR signaling pathway
|
154 |
0.321 |
|
97 |
|
Cyclins and Cell Cycle Regulation
|
72 |
0.321 |
|
98 |
|
Caloric restriction and aging
|
9 |
0.321 |
|
99 |
|
MAPK Signaling: Oxidative Stress
|
79 |
0.321 |
|
100 |
|
Acyl chain remodelling of PE
|
46 |
0.321 |
|
101 |
|
Formation of HIV elongation complex in the absence of HIV Tat
|
180 |
0.321 |
|
102 |
|
Immune response IL-23 signaling pathway
|
160 |
0.321 |
|
103 |
|
Pathogenesis of ALS
|
25 |
0.321 |
|
104 |
|
TGF-Beta Pathway
|
653 |
0.321 |
|
105 |
|
Gastric cancer network 2
|
31 |
0.321 |
|
106 |
|
MAPK Pathway
|
88 |
0.321 |
|
107 |
|
Thyroid hormones production and peripheral downstream signaling effects
|
83 |
0.321 |
|
108 |
|
22q11.2 copy number variation syndrome
|
130 |
0.321 |
|
109 |
|
CKAP4 signaling pathway map
|
108 |
0.321 |
|
110 |
|
Regulation of TP53 Activity through Acetylation
|
30 |
0.321 |
|
111 |
|
mTOR Pathway
|
58 |
0.321 |
|
112 |
|
Packaging Of Telomere Ends
|
203 |
0.321 |
|
113 |
|
TNFR1 Pathway
|
190 |
0.321 |
|
114 |
|
Dopamine-DARPP32 Feedback onto cAMP Pathway
|
228 |
0.321 |
Genes names |
- Tumor Protein P53 Binding Protein 2
|
|
115 |
|
Cell cycle
|
137 |
0.321 |
|
116 |
|
Epithelial to mesenchymal transition in colorectal cancer
|
161 |
0.321 |
|
117 |
|
TP53 network
|
18 |
0.321 |
|
118 |
|
Response to elevated platelet cytosolic Ca2+
|
621 |
0.321 |
|
119 |
|
Loss of function of TP53 in cancer due to loss of tetramerization ability
|
1 |
0.321 |
|
120 |
|
Golgi-to-ER retrograde transport
|
369 |
0.321 |
|
121 |
|
Cytokine Signaling in Immune system
|
732 |
0.321 |
|
122 |
|
Chaperonin-mediated protein folding
|
97 |
0.321 |
|
123 |
|
Genotoxicity pathway
|
60 |
0.321 |
Genes names |
- Tumor Protein P53 Inducible Protein 3
|
|
124 |
|
Pre-NOTCH Expression and Processing
|
235 |
0.321 |
|
125 |
|
Inhibition of Ribosome Biogenesis by p14(ARF)
|
22 |
0.321 |
|
126 |
|
Development IGF-1 receptor signaling
|
110 |
0.321 |
|
127 |
|
ncRNAs involved in Wnt signaling in hepatocellular carcinoma
|
220 |
0.321 |
|
128 |
|
Interleukin-4 and Interleukin-13 signaling
|
108 |
0.321 |
|
129 |
|
Cell cycle Role of 14-3-3 proteins in cell cycle regulation
|
30 |
0.321 |
|
130 |
|
Integrated breast cancer pathway
|
150 |
0.321 |
|
131 |
|
p75(NTR)-mediated signaling
|
61 |
0.321 |
|
132 |
|
Phospholipase-C Pathway
|
503 |
0.321 |
|
133 |
|
Photodynamic therapy-induced HIF-1 survival signaling
|
37 |
0.321 |
|
134 |
|
NF-kappaB Pathway
|
152 |
0.321 |
|
135 |
|
Copper homeostasis
|
51 |
0.321 |
|
136 |
|
Bladder cancer
|
40 |
0.321 |
|
137 |
|
TCA cycle in senescence
|
10 |
0.321 |
|
138 |
|
Nervous system development
|
1168 |
0.321 |
Genes names |
- P53 Apoptosis Effector Related To PMP22
|
|
139 |
|
Kynurenine pathway and links to cell senescence
|
27 |
0.321 |
|
140 |
|
TP53 Regulates Metabolic Genes
|
87 |
0.321 |
|
141 |
|
Head and neck squamous cell carcinoma
|
73 |
0.321 |
|
142 |
|
Pentose phosphate pathway in senescent cells
|
5 |
0.321 |
|
143 |
|
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha
|
17 |
0.321 |
|
144 |
|
NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence
|
17 |
0.321 |
|
145 |
|
DYRK1A involvement regarding cell proliferation in brain development
|
62 |
0.321 |
|
146 |
|
Transcription_P53 signaling pathway
|
54 |
0.321 |
|
147 |
|
Retinoblastoma gene in cancer
|
86 |
0.321 |
|
148 |
|
lncRNA-mediated mechanisms of therapeutic resistance
|
6 |
0.321 |
|
149 |
|
Glucocorticoid receptor regulatory network
|
77 |
0.321 |
|
150 |
|
Spinal cord injury
|
115 |
0.321 |
|
151 |
|
Signal transduction_JNK pathway
|
44 |
0.321 |
|
152 |
|
Netrin-UNC5B signaling pathway
|
52 |
0.321 |
|
153 |
|
Burn wound healing
|
75 |
0.321 |
|
154 |
|
Validated targets of C-MYC transcriptional activation
|
80 |
0.321 |
|
155 |
|
Senescence and autophagy in cancer
|
105 |
0.321 |
|
156 |
|
Prader-Willi and Angelman syndrome
|
60 |
0.321 |
|
157 |
|
Signal Transduction
|
2590 |
0.321 |
|
158 |
|
Ferroptosis
|
64 |
0.321 |
|
159 |
|
SARS-CoV-2 innate immunity evasion and cell-specific immune response
|
50 |
0.321 |
Genes names |
- Tumor Protein P53 Inducible Protein 3
|
|
160 |
|
MicroRNA network associated with chronic lymphocytic leukemia
|
6 |
0.321 |
|
161 |
|
RIPK1-mediated regulated necrosis
|
60 |
0.321 |
|
162 |
|
Hair follicle development: cytodifferentiation - part 3 of 3
|
54 |
0.321 |
Genes names |
- P53 Apoptosis Effector Related To PMP22
|
|
163 |
|
Toll-like receptor signaling pathway
|
285 |
0.321 |
|
164 |
|
Toll Comparative Pathway
|
101 |
0.321 |
|
165 |
|
Metabolic reprogramming in pancreatic cancer
|
42 |
0.321 |
|
166 |
|
Activation of cAMP-Dependent PKA
|
632 |
0.321 |
Genes names |
- Tumor Protein P53 Binding Protein 2
|
|
167 |
|
4-1BB Pathway
|
173 |
0.321 |
|
168 |
|
Mammary gland development pathway - Involution (Stage 4 of 4)
|
10 |
0.321 |
|
169 |
|
Infectious disease
|
1747 |
0.321 |
|
170 |
|
Innate Immune System
|
2025 |
0.321 |
|
171 |
|
Folate metabolism
|
11 |
0.321 |
|
172 |
|
Androgen receptor network in prostate cancer
|
105 |
0.321 |
|
173 |
|
Fluoropyrimidine activity
|
34 |
0.321 |
|
174 |
|
Colorectal Cancer Metastasis
|
165 |
0.321 |
|
175 |
|
Hepatitis C and hepatocellular carcinoma
|
55 |
0.321 |
|
176 |
|
HIF1Alpha Pathway
|
54 |
0.321 |
|
177 |
|
Loss of proteins required for interphase microtubule organization from the centrosome
|
226 |
0.321 |
|
178 |
|
RNA Polymerase I Promoter Opening
|
509 |
0.321 |
|